# Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/secukinumab-improves-active-psoriatic-arthritis-symptoms-and-inhibits/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Philip J. Mease,Désirée van der Heijde,Robert Landewé,Shephard Mpofu,Proton Rahman,Hasan Tahir,Atul Singhal,Elke Boettcher,Sandra Navarra,Karin Meiser,Aimee Readie,Luminita Pricop,Kenneth Abrams |
| Citations | 302 |
| DOI | 10.1136/annrheumdis-2017-212687 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ard.bmj.com/content/annrheumdis/77/6/890.full.pdf |
| OpenAlex ID | https://openalex.org/W2789710874 |
| PMID | 29550766 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Sandra Navarra](https://scholariq.org/researchers/sandra-navarra/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Paper topics

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.